OSE IMMUNOTHERAPEUTICS: ifrs:BasicEarningsLossPerShare
| Value | {"amount": 1.71} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | OSE IMMUNOTHERAPEUTICS |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T22:30:45.671935+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/26c6d6c1-d7f6-4b29-bf8a-b6cfe234275d
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:969500HIUWVGY6NZSM05:2025-12-31Retrieved: 2026-08-23T22:30:45.671935+02:00
Raw response sha256:
1c030fbf6937c66989de5e264e1a01e4…Cite as: FACTANKER, https://factanker.com/fact/26c6d6c1-d7f6-4b29-bf8a-b6cfe234275d
History
- no predecessors — first report